Trials / Terminated
TerminatedNCT01519973
Optimization of SPECT Imaging
Optimization of SPECT Cardiac Imaging Through Compensation for Attenuation, Resolution Loss and Scatter - The OSCARS
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Ottawa Heart Institute Research Corporation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Single Photon Emission Computed Tomography (SPECT) is a 3D nuclear medicine imaging technique that is used extensively to study the heart and diagnose heart disease. There are three major limitations in SPECT imaging: attenuation or loss of signal, scattering of the signal in the patient tissues and resolution, where the signal gets blurrier the further the nuclear activity is away from the camera. New software, Evolution for CardiacTM, by GE Healthcare and new cameras with computed tomography (CT) decrease the time needed for images to be obtained while maintaining image quality. Evaluation is needed before they become standard of care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | SPECT/CT processed with Evolution for CardiacTM software | SPECT/CT to be compared with PET/CT |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2012-08-01
- Completion
- 2012-08-01
- First posted
- 2012-01-27
- Last updated
- 2017-04-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01519973. Inclusion in this directory is not an endorsement.